MarketingRx roundup: Astellas menopause drug led NFL TV spending; A podcast’s deep dive into Novo’s history

Astel­las in­tro­duces menopause drug to NFL au­di­ence: Astel­las spent more mon­ey ad­ver­tis­ing its menopause drug Veozah than any oth­er new brand on reg­u­lar NFL broad­casts in the 2023-2024 sea­son so far, ac­cord­ing to da­ta from re­al-time TV ad track­er iS­pot.tv. It spent $24.1 mil­lion from Sep­tem­ber through the first week of Jan­u­ary, with ES­PN, BET, AT&T, The Farmer’s Dog and Chili’s round­ing out the top new ad­ver­tis­ers this sea­son. Pfiz­er’s Nurtec and As­traZeneca’s Breztri Aeros­phere al­so made the top 10 new brands list at nos. 7 and 8, re­spec­tive­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.